The Oncology Institute Names Kristin England as Chief Administrative Officer
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI), a leading value-based oncology group in the United States, has appointed Kristin England as its new Chief Administrative Officer (CAO), effective July 7, 2025. In this newly created position, England will be responsible for overseeing Enterprise Central Business Operations and Technology Strategy across TOI's national operations.
England joins TOI with over 20 years of healthcare management experience, previously serving as a senior executive at McKesson's US Oncology Network, where she specialized in revenue cycle optimization and practice management systems improvement. CEO Daniel Virnich emphasized that England's appointment comes at a crucial time as TOI focuses on scaling its MSO model and strengthening its value-based care approach.
Positive
- Appointment of experienced healthcare executive with over 20 years of leadership experience
- Strategic hire to support national expansion and operational efficiency
- Strengthening of senior management team with expertise in revenue cycle optimization
Negative
- None.
CERRITOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Kristin England has joined the organization as Chief Administrative Officer (CAO), effective July 7, 2025. In this newly established role, England will oversee Enterprise Central Business Operations and Technology Strategy and Enablement across TOI’s expanding national footprint.
England brings over two decades of leadership experience in healthcare management and operations, most recently serving as a senior executive within McKesson’s US Oncology Network. There, she led high-performing teams focused on optimizing revenue cycle performance and streamlining practice management systems to drive operational efficiency and service delivery.
“We’re thrilled to welcome Kristin to our senior leadership team at such a pivotal time for TOI,” said Daniel Virnich, CEO of The Oncology Institute. “Her track record of driving operational excellence and aligning systems for sustainable growth and efficiency will be instrumental as we scale our MSO model and deepen our commitment to value-based care.”
“It is a privilege to join The Oncology Institute at such a transformative time. I look forward to advancing our strategic priorities and supporting TOI’s continued growth through operational excellence and disciplined execution,” said England.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients, including access to clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better.
For more information, visit www.theoncologyinstitute.com
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
FAQ
Who is the new Chief Administrative Officer (CAO) of The Oncology Institute (NASDAQ: TOI)?
What is Kristin England's role as CAO at The Oncology Institute (TOI)?
What is Kristin England's previous experience before joining TOI?
Why did The Oncology Institute create the CAO position?
